INHIBITION OF PHOSPHOINOSITIDE-3-KINASE (PI3K)/AKT DEPENDENT SIGNALING INHIBITS [CA2+]I OSCILLATIONS IN HL-1 CARDIOMYOCYTES

被引：0
|
作者：
Graves, B. [1 ]
Wondergem, R. [1 ]
Simerly, T. [1 ]
Li, C. [1 ]
Williams, D. L. [1 ]
机构：
[1] E Tennessee State Univ, Johnson City, TN 37614 USA
来源：
SHOCK | 2011年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：41 / 41
页数：1
相关论文
共 50 条
  • [21] Inhibition of PI3K/Akt/mTOR Signaling by Natural Products
    Huang, Shile
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2013, 13 (07) : 967 - 970
  • [22] Impact of PI3K (Phosphoinositide 3-Kinase Alpha) Inhibition on Hemostasis and Thrombosis
    Laurent, Pierre-Alexandre
    Hechler, Beatrice
    Solinhac, Romain
    Ragab, Ashraf
    Cabou, Cendrine
    Anquetil, Typhaine
    Severin, Sonia
    Denis, Cecile V.
    Mangin, Pierre H.
    Vanhaesebroeck, Bart
    Payrastre, Bernard
    Gratacap, Marie-Pierre
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (09) : 2041 - 2053
  • [23] Euphorbia fischeriana Steud inhibits malignant melanoma via modulation of the phosphoinositide-3-kinase/Akt signaling pathway
    Dong, Meng-Hua
    Zhang, Qian
    Wang, Yuan-Yuan
    Zhou, Bai-Sui
    Sun, Yu-Fei
    Fu, Qiang
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (04) : 1475 - 1480
  • [24] The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL
    K Balakrishnan
    M Peluso
    M Fu
    N Y Rosin
    J A Burger
    W G Wierda
    M J Keating
    K Faia
    S O'Brien
    J L Kutok
    V Gandhi
    [J]. Leukemia, 2015, 29 : 1811 - 1822
  • [25] Free-Wilson Analysis of Comprehensive Data on Phosphoinositide-3-kinase (PI3K) Inhibitors Reveals Importance of N-Methylation for PI3Kδ Activity
    Barnes, Lydia
    Blaber, Hollie
    Brooks, David T. K.
    Byers, Lewis
    Buckley, Daniel
    Byron, Zoe C.
    Chilvers, Richard G.
    Cochrane, Liam
    Cooney, Edward
    Damian, Heather A.
    Francis, Luke
    He, Daniel Fu
    Grace, Jack M. J.
    Green, Harley J.
    Hogarth, Edmund J. P.
    Jusu, Leyla
    Killalea, C. Elizabeth
    King, Oliver
    Lambert, Joseph
    Lee, Zoe J.
    Lima, Nuria S.
    Long, Christina L.
    Mackinnon, May-Li
    Mahdy, Shusha
    Matthews-Wright, Jolyon
    Millward, Makenzie J.
    Meehan, Matthew F.
    Merrett, Christopher
    Morrison, Lisa
    Parke, Hal R. I.
    Payne, Charlotte
    Payne, Lawrence
    Pike, Craig
    Seal, Alexander
    Senior, Aaron J.
    Smith, Keenan M.
    Stanelyte, Kamile
    Stillibrand, Joe
    Szpara, Rachel
    Taday, Freya F. H.
    Threadgould, Antony M.
    Trainor, Rohan J.
    Waters, Jordan
    Williams, Oliver
    Wong, Carrie K. W.
    Wood, Katherine
    Barton, Nick
    Gruszka, Anna
    Henley, Zoe
    Rowedder, James E.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (22) : 10402 - 10422
  • [26] The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL
    Balakrishnan, K.
    Peluso, M.
    Fu, M.
    Rosin, N. Y.
    Burger, J. A.
    Wierda, W. G.
    Keating, M. J.
    Faia, K.
    O'Brien, S.
    Kutok, J. L.
    Gandhi, V.
    [J]. LEUKEMIA, 2015, 29 (09) : 1811 - 1822
  • [27] Advances in the Development of Class I Phosphoinositide 3-Kinase (PI3K) Inhibitors
    Sabbah, Dima A.
    Hu, Jian
    Zhong, Haizhen A.
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (13) : 1413 - 1426
  • [28] Mutant IDH1 Inhibits PI3K/Akt Signaling in Human Glioma
    Birner, Peter
    Pusch, Stefan
    Christov, Christo
    Mihaylova, Stiliana
    Toumangelova-Uzeir, Kalina
    Natchev, Sevdalin
    Schoppmann, Sebastian F.
    Tchorbanov, Andrey
    Streubel, Berthold
    Tuettenberg, Jochen
    Guentchev, Marin
    [J]. CANCER, 2014, 120 (16) : 2440 - 2447
  • [29] Quasi 4D-QSAR and 3D-QSAR study of the pan class I phosphoinositide-3-kinase (PI3K) inhibitors
    Safavi-Sohi, Reihaneh
    Ghasemi, Jahan B.
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (04) : 1587 - 1596
  • [30] Phase I trial of PX-866, a novel phosphoinositide-3-kinase (PI-3K) inhibitor
    Jimeno, A.
    Hong, D. S.
    Hecker, S.
    Clement, R.
    Kurzrock, R.
    Pestano, L. A.
    Hiscox, A.
    Leos, R. A.
    Kirkpatrick, D. L.
    Eckhardt, S. G.
    Herbst, R. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345